Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to Record 8.0% Y-O-Y Growth Rate in 2022 | Evolving Opportunities with Amgen Inc. & Apollomics Inc. | Technavio

NEW YORK, June 21, 2022 /PRNewswire/ — The epidermal growth factor receptor (EGFR) inhibitors market size is expected to grow by USD 6.75 billion from 2021 to 2026 at a CAGR of 8.6% as per the latest market report by Technavio. The epidermal growth factor receptor (EGFR) inhibitors…